Last reviewed · How we verify
NCT04824599
Regional Anesthesia and Partial Mastectomy
NA trial testing PECS II in Breast Neoplasm in 60 participants. Completed in 1 May 2022.
1 May 2022
Quick facts
| Lead sponsor | Karlstad Central Hospital |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | prevention |
| Enrollment | 60 |
| Start date | 19 February 2021 |
| Primary completion | 1 May 2022 |
| Estimated completion | 1 May 2022 |
| Sites | 1 location across Sweden |
Drugs / interventions tested
- PECS II
- Local anesthetic infiltration — full drug profile →
- Subcutaneus local anesthetic infiltration
- Ropivacaine (ROPIVACAINE) — full drug profile →
- bk medical Flex Focus 500 Ultrasound Machine
Conditions studied
- Breast Neoplasm — all drugs for Breast Neoplasm →
Sponsor
Karlstad Central Hospital
Who can join
18 and older, female only, with Breast Neoplasm. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Pectoralis nerves plane block (PECS) first described by Blanco in 2011 has become part of postoperative pain management in breast surgery, thoracic surgery and thoracic trauma. The combination of low complication risk and easiness in mastering of PECS block has made it an interesting alternative to thoracic epidural anesthesia (TEDA) and paravertebral blockade (PVB) for pain treatment after breast surgery. Several studies showed good results when PECS was compared to PVB. PECS blockade however is a procedure requiring some resources in the operating room. An alternative approach is to inject local anesthetics (LA) in the operation field by the surgeon. The hypothesis' tested in this study is primarily: that PECS blockade is superior to LA being injected by surgeon in the operating field measured by end points such as: post-operative pain, post-operative analgesics use, post-operative nausea or vomiting (PONV) and length of stay in the post anesthesia care unit (PACU).
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Interpectoral and Pectoserratus Plane Block vs. Local Anesthetic Infiltration for Partial Mastectomy: A Prospective Randomized Trial.
Eisler P, Zimmermann S, Henningsson R. · · 2024 · cited 1× · PMID 38550709 · DOI 10.1155/2024/9989997
Verify or expand the search:
- PubMed search for NCT04824599
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Breast Neoplasm
Currently open trials in the same condition.
- NCT07054723 — Surviving Daily Life · recruiting
- NCT06839001 — CRYoablation for Small Tumors As Local Treatment - SIX Trial · Phase 3 · recruiting
- NCT06672302 — A Prospective Study to Develop and Clinically Validate an in Vitro Diagnostic Medical Device That Uses Blood to Classify · recruiting
- NCT06255808 — Development of Assist Tool for Breast Examination Using the Principle of Ultrasonic Sensor · active not recruiting
- NCT06622967 — KNUCH CadAI-B-1(KCB-1) · NA · active not recruiting
Other Karlstad Central Hospital trials
Trials by the same sponsor.
- NCT06336746 — Cardiac Performance During Steep Trendelenburg Position in Patients Undergoing Robotic Surgery Surgery. · recruiting
- NCT05602662 — Music as a Complement to Pharmacological Sedation in Ventilator Treated ICU Patients. · NA · recruiting
- NCT04675840 — Intrathecal Morphine for Robotic-assisted Laparoscopic Hysterectomy. · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04824599 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Karlstad Central Hospital
- Last refreshed: 7 September 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04824599.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing